612 related articles for article (PubMed ID: 21965732)
21. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines.
Liu ZB; Hou YF; ; Di GH; Wu J; Shen ZZ; Shao ZM
J Cell Biochem; 2009 Sep; 108(1):195-206. PubMed ID: 19562667
[TBL] [Abstract][Full Text] [Related]
22. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
23. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231.
Kim JB; Lee KM; Ko E; Han W; Lee JE; Shin I; Bae JY; Kim S; Noh DY
Planta Med; 2008 Jan; 74(1):39-42. PubMed ID: 18203057
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antitumor activity and QSAR studies of some 4-aminomethylidene derivatives of edaravone.
Marković V; Erić S; Juranić ZD; Stanojković T; Joksović L; Ranković B; Kosanić M; Joksović MD
Bioorg Chem; 2011 Feb; 39(1):18-27. PubMed ID: 21078519
[TBL] [Abstract][Full Text] [Related]
25. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.
Vibet S; Mahéo K; Goré J; Dubois P; Bougnoux P; Chourpa I
Drug Metab Dispos; 2007 May; 35(5):822-8. PubMed ID: 17296624
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
27. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines.
Patitungkho S; Adsule S; Dandawate P; Padhye S; Ahmad A; Sarkar FH
Bioorg Med Chem Lett; 2011 Mar; 21(6):1802-6. PubMed ID: 21316236
[TBL] [Abstract][Full Text] [Related]
29. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study.
Nakhjiri M; Safavi M; Alipour E; Emami S; Atash AF; Jafari-Zavareh M; Ardestani SK; Khoshneviszadeh M; Foroumadi A; Shafiee A
Eur J Med Chem; 2012 Apr; 50():113-23. PubMed ID: 22341788
[TBL] [Abstract][Full Text] [Related]
30. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
31. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines.
Colin C; Salamone S; Grillier-Vuissoz I; Boisbrun M; Kuntz S; Lecomte J; Chapleur Y; Flament S
Breast Cancer Res Treat; 2010 Nov; 124(1):101-10. PubMed ID: 20054646
[TBL] [Abstract][Full Text] [Related]
32. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
Liu ZJ; Lee WJ; Zhu BT
Cancer Res; 2005 Jul; 65(13):5802-11. PubMed ID: 15994956
[TBL] [Abstract][Full Text] [Related]
33. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Shallal HM; Russu WA
Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632
[TBL] [Abstract][Full Text] [Related]
34. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents.
Shankar R; Chakravarti B; Singh US; Ansari MI; Deshpande S; Dwivedi SK; Bid HK; Konwar R; Kharkwal G; Chandra V; Dwivedi A; Hajela K
Bioorg Med Chem; 2009 Jun; 17(11):3847-56. PubMed ID: 19423356
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anti-breast cancer activity of new indolylquinone derivatives.
Li X; Zheng SL; Li X; Li JL; Qiang O; Liu R; He L
Eur J Med Chem; 2012 Aug; 54():42-8. PubMed ID: 22658083
[TBL] [Abstract][Full Text] [Related]
38. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
[TBL] [Abstract][Full Text] [Related]
39. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
40. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]